Men are more susceptible than women to skin infections caused by Staphylococcus aureus bacteria, but the biological basis for ...

Scientists have designed nanoagents that act like smart drug-delivery capsules—carrying an antibiotic deep into bacterial ...

Early research suggests a new nasal spray vaccine could protect against multiple respiratory threats.

Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia is a well-recognized cause of bacterial pneumonia, resulting in increased morbidity and mortality worldwide. Traditional antibiotics face ...

Backed by a portfolio of more than 60 patents worldwide, Vyv's proprietary 405nm technology has been proven effective against a wide range of bacteria, viruses, and fungi*. This breakthrough aligns ...

A Stanford University School of Medicine research team has developed a vaccine technology that can prevent respiratory ...

In the news release, InSinkErator Launches LEDefense (TM) Powered by Vyv's Patented 405nm Antimicrobial Light Technology, issued 04-Mar-2026 by Vyv over PR Newswire, we are advised by the company that ...

New Product Integrates Vyv's Proprietary 405nm Antimicrobial Light Technology to Kill* Odor-Causing Bacteria LATHAM, N.Y., March 4, 2026 /PRNewswire/ -- VYV today announced that at KBIS 2026, ...

In today’s interconnected world, the spread of pathogenic microorganisms poses a significant challenge to global public health, economic stability, and ...

Learn how reseachers are working to engineer certain bacteria to consume tumors.

Science Applications International Corp. is challenging a $1.4 billion award that went to Accenture's U.S. federal subsidiary to support the Army Corps of Engineers' Castle-Net, a cybersecurity system ...

Researchers have discovered that while bone infections after pediatric brain surgery are rare, aggressive treatment and a watchful eye for tuberculosis lead to excellent recovery rates.